FDA — authorised 21 October 1988
- Application: NDA019667
- Marketing authorisation holder: NOVARTIS
- Local brand name: SANDOSTATIN
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 SOM230 LAR in United States
FDA authorised SOM230 LAR on 21 October 1988
Marketing authorisation
Frequently asked questions
Is SOM230 LAR approved in United States?
Yes. FDA authorised it on 21 October 1988.
Who is the marketing authorisation holder for SOM230 LAR in United States?
NOVARTIS holds the US marketing authorisation.